INM Stock Summary and Trading Ideas (Inmed Pharmaceuticals - Common Shares | NASDAQ:INM)

InMed Pharmaceuticals Inc is a pharmaceutical company developing a pipeline of disease-modifying small molecule drug candidates targeting CB1 and CB2 receptors. The company's pipeline consists of three separate programs in the treatment of Alzheimer's, ocular and dermatological indications.

Inmed Pharmaceuticals - Common Shares trades on the NASDAQ stock market under the symbol INM.

As of August 17, 2026, INM stock price declined to $1.46 with 71,840 million shares trading.

INM has a beta of 2.31, meaning it tends to be more sensitive to market movements. INM has a correlation of 0.05 to the broad based SPY ETF.

INM has a market cap of $7.80 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, INM traded as high as $41.60 and as low as $.58.

INM has underperformed the market in the last year with a price return of -37.6% while the SPY ETF gained +21.0%. However, in the short term, INM had mixed performance relative to the market. It has outperformed in the last 3 months, returning +124.6% vs +3.5% return in SPY. But in the last 2 weeks, INM shares have been beat by the market, returning -0.7% compared to an SPY return of +3.4%.

INM support price is $1.39 and resistance is $1.55 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that INM shares will trade within this expected range on the day.